Parschauer Karah Herdman 4
4 · Ultragenyx Pharmaceutical Inc. · Filed Sep 12, 2025
Insider Transaction Report
Form 4
Parschauer Karah Herdman
EVP and Chief Legal Officer
Transactions
- Sale
Common Stock
2025-09-12$31.17/sh−2,450$76,367→ 73,271 total
Footnotes (2)
- [F1]Includes 434 shares acquired under the Company's A&R 2014 Employee Stock Purchase Plan on April 30, 2025.
- [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.